• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Pfizer

Anonymous board for Pfizer.
Replies
14
Views
5K
Anonymous
Replies
22
Views
4K
Anonymous
Replies
16
Views
2K
Anonymous
Replies
1
Views
808
Anonymous
Replies
12
Views
2K
Anonymous
Replies
19
Views
3K
Anonymous
Replies
11
Views
3K
Anonymous
Replies
102
Views
13K
Anonymous
Replies
6
Views
1K
Anonymous
Replies
7
Views
2K
Anonymous
Replies
42
Views
8K
Anonymous
Replies
85
Views
6K
Anonymous